TABLE 2.
Part 2 study population
| Parameter | PBO (n = 10) | 10 mg EP (n = 9) | 40 mg EP (n = 9) | 75 mg EP (n = 9) | Total (N = 37) |
|---|---|---|---|---|---|
| Age (years) | |||||
| Median | 41 | 36 | 35 | 33 | 36 |
| Min, max | 23, 55 | 26, 51 | 25, 48 | 24, 51 | 23, 55 |
| Male sex a | 4 (40) | 7 (78) | 8 (89) | 7 (78) | 26 (70) |
| Hispanic or Latino a | 2 (20) | 3 (33) | 2 (22) | 1 (11) | 8 (22) |
| Race a | |||||
| White | 2 (20) | 3 (33) | 2 (22) | 2 (22) | 9 (24) |
| Black or AA | 7 (70) | 6 (67) | 7 (78) | 7 (78) | 27 (73) |
| Asian | 0 | 0 | 0 | 0 | 0 |
| Other | 1 (10) | 0 | 0 | 0 | 1 (3) |
| BMI (kg/m2) | |||||
| Median | 25 | 27 | 26 | 27 | 27 |
| Min, max | 21, 29 | 22, 31 | 20, 31 | 22, 31 | 20, 31 |
Abbreviations: AA, African American; BMI, body mass index; EP, extemporaneously prepared; PBO, placebo; PP, pre‐prepared.
a
Data expressed as number (%).